Comparison of results of the CellTiter Blue, the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide), and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts.
Advanced glycation endproducts (AGEs) arise in vivo from the reaction of proteins with sugars or dicarbonyl compounds. They are thought to be involved in the pathogenesis of several diseases such as atherosclerosis, diabetes mellitus, renal failure, and Alzheimer's disease (AD). Several binding molecules for AGEs have been described and it is assumed that many of the effects of AGEs are mediated by receptors like the receptor for AGEs (RAGE). AGEs are known to induce the release of inflammatory cytokines from activated glia in the AD brain and thus AGEs affect the cell viability of neurons and glia. In cell culture experiments controversial effects of AGEs on cell growth and viability were reported by different research groups ranging from stimulation to inhibition of the cell viability. In the present study, the effect of in vitro prepared highly modified AGEs on the viability and the membrane integrity of cultured brain cells was investigated. Three different brain cell lines were treated with glucose human serum albumin AGEs (Glc-AGEs) and methyl glyoxal human serum albumin AGEs (MG-AGEs). To investigate the effect of these model AGEs on cell viability the CellTiter Blue (CTB) and the tetrazolium (3-[4,5-dimethylthioazol-2-yl]-2,5-diphenyl tetrazolium bromide) (MTT) were used. The membrane integrity after exposure to AGEs was assayed using the lactate dehydrogenase (LDH) assay. When using the CTB assay for evaluation all AGEs were found to reduce the viability compared with the native protein in all three cell lines. Additionally, all AGEs were found to affect the membrane integrity compared with the native protein in all cell lines. When using the MTT assay for evaluation only MG-AGEs were found to cause a decrease in the viability in all cell lines used. The results of the MTT assay in Glc-AGEs treated cells varied between the cell lines. To gain a deeper understanding of the cellular responses after exposure of cells to AGEs, the present study compares results obtained when using the CTB, the MTT or the LDH assay in identically AGE treated cells.
Bigl
Katrin
K
Interdisciplinary Centre of Clinical Research (IZKF), University of Leipzig, Inselstr. 22, 04103 Leipzig, Germany. katrin.bigl@yahoo.de
Schmitt
Annett
A
Meiners
Ina
I
Münch
Gerald
G
Arendt
Thomas
T
D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D002452:Cell Count; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D004396:Coloring Agents; D017127:Glycation End Products, Advanced / Q000633:toxicity*; D006801:Humans; D007202:Indicators and Reagents; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D051379:Mice; D011506:Proteins / Q000378:metabolism; D015203:Reproducibility of Results; D012709:Serum Albumin / Q000378:metabolism; D013778:Tetrazolium Salts; D013844:Thiazoles
D004396:Coloring Agents; D017127:Glycation End Products, Advanced; D007202:Indicators and Reagents; D011506:Proteins; D012709:Serum Albumin; D013778:Tetrazolium Salts; D013844:Thiazoles; D007770:L-Lactate Dehydrogenase; C022616:thiazolyl blue